PIK3CA mutations in nasopharyngeal carcinoma [4]

International Journal of Cancer

Volumn 118, Issue 4, 2006, Pages 1065-1067

  Or, Yvonne Yan Yan ^a   Hui, Angela Bik Yu ^a   To, Ka Fai ^a   Lam, Cleo Nga Yee ^a   Lo, Kwok Wai ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PHOSPHATIDYLINOSITOL 3 KINASE;

CANCER CELL CULTURE; CARCINOGENESIS; COLORECTAL CANCER; CYTOGENETICS; DNA SEQUENCE; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE FUNCTION; GENE MUTATION; GENETIC EPIDEMIOLOGY; HUMAN; LETTER; MUTATIONAL ANALYSIS; NASOPHARYNX CARCINOMA; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; ONCOGENE; OVARY CANCER; PIK3CA GENE; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BASE SEQUENCE; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; DNA MUTATIONAL ANALYSIS; GENE AMPLIFICATION; GENE DOSAGE; HUMANS; MOLECULAR SEQUENCE DATA; NASOPHARYNGEAL NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 31544481905     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21444     Document Type: Letter

References (15)

1. Hui ABY, Lo KW, Leung SF, Teo P, Mak MKF, To KF, Wong N, Choi PHK, Lee JCK, Huang DP. Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridization. Int J Cancer 1999;48:498-503.
2. Or YY, Hui AB, Tam KY, Huang DP, Lo KW. Characterization of chromosome 3q and 12q amplicons in nasopharyngeal carcinoma cell lines. Int J Oncol 2005;26:49-56.
3. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002;296:1655-57.
4. Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB, Gray JW. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 1999;21:99-102.
5. Ma YY, Wei SJ, Lin YC, Lung JC, Chang TC, Whang-Peng J, Liu JM, Yang DM, Yang WK, Shen CY. PIK3CA as an oncogene in cervical cancer. Oncogene 2000;19:2739-44.
6. Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, Willson JK, Markowitz S, et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 2004;304:554.
7. Broderick DK, Di C, Parrett TJ, Samuels YR, Cummins JM, McLendon RE, Fults DW, Velculescu VE, Bigner DD, Yan H. Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas. Cancer Res 2004;64:5048-50.
8. Campbell IG, Russell SE, Choong DYH, Montgomery KG, Ciavarella ML, Hooi CSF, Cristiano BE, Pearson RB, Phillips WA. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res 2004;64:7678-81.
9. Wang Y, Helland A, Holm R, Kristensen GB, Børresen-Dale A. PIK3CA mutations in advanced ovarian carcinomas. Hum Mutat 2005;25:322.
10. Saal LH, Holm K, Maurer M, Memeo L, Su T, Wang X, Yu JS, Malmstrom PO, Mansukhani M, Enoksson J, Hibshoosh H, Borg A, et al. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res 2005;65:2554-9.
11. Kang S, Bader AG, Vogt PK. Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci USA 2005;102:802-7.
12. Levine DA, Bogomolniy F, Yee CJ, Lash A, Barakat RR, Borgen PI, Boyd J. Frequent mutation of the PIK3CA gene in ovarian and breast cancers. Clin Cancer Res 2005;11:2875-8.
13. Li VS, Wong CW, Chan TL, Chan AS, Zhao W, Chu KM, So S, Chen X, Yuen ST, Leung SY. Mutations of PIK3CA in gastric adenocarcinoma. BMC Cancer 2005;5:29.
14. Lee JW, Soung YH, Kim SY, Lee HW, Park WS, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene 2005;24:1477-80.
15. Hui ABY, Or YY, Takano H, Tsang RKY, To KF, Guan XY, Sham JST, Hong KWK, Lam CNY, van Hasselt CA, Kuo WL, Gray JW, et al. Array-based CGH analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma. Cancer Res 2005, revised.